Skip to main content

Table 3 Tumor characteristics in patients with colorectal liver metastasis who underwent minor and major minimally invasive liver surgery (MILS)

From: Robotic and laparoscopic liver surgery for colorectal liver metastases: an experience from a German Academic Center

 

LLS

n (% or SD)

RLS

n (% or SD)

Total

n (% or SD)

Tumor localization

 Left hepatic lobe

6 (46.2)

6 (50.0)

12 (48.0)

 Right hepatic lobe

3 (23.1)

4 (33.3)

7 (28.0)

 Bilobar

4 (30.8)

2 (16.7)

6 (24.0)

Number of lesions

 1

8 (61.5)

6 (50.0)

14 (56.0)

 2

3 (23.1)

3 (25.0)

6 (24.0)

 3

1 (7.7)

1 (8.3)

2 (8.0)

 > 3

1 (7.7)

2 (16.7)

3 (12.0)

Time of occurrence

 Synchronous

6 (46.2)

4 (33.3)

10 (40.0)

 Metachronous

5 (38.5)

8 (66.7)

13 (52.0)

 Missing data

2 (15.4)

0 (0.0)

2 (8.0)

Size of tumor (cm)

2.8 (1.9)

4.2 (1.6)

3.5 (1.8)

Preoperative chemotherapy

 Yes

10 (76.9)

10 (83.3)

20 (80.0)

 No

3 (23.1)

1 (8.3)

4 (16.0)

 Missing data

0 (0.0)

1 (8.3)

1 (4.0)

CEA (ng/ml)

40.1 (51.8)

171.5 (404.8)

112.4 (303.1)

  1. LLS laparoscopic liver surgery, MILS minimally invasive liver surgery, CEA carcinoembryonic antigen, RLS robotic liver surgery, SD standard deviation